Int. J. Mol. Sci. 2014, 15(6), 10669-10723; doi:10.3390/ijms150610669

Carriers in Cell-Based Therapies for Neurological Disorders

1email, 2email and 1,3,* email
Received: 14 March 2014; in revised form: 19 May 2014 / Accepted: 30 May 2014 / Published: 13 June 2014
(This article belongs to the Special Issue Neuroprotective Strategies 2014)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: There is a pressing need for long-term neuroprotective and neuroregenerative therapies to promote full function recovery of injuries in the human nervous system resulting from trauma, stroke or degenerative diseases. Although cell-based therapies are promising in supporting repair and regeneration, direct introduction to the injury site is plagued by problems such as low transplanted cell survival rate, limited graft integration, immunorejection, and tumor formation. Neural tissue engineering offers an integrative and multifaceted approach to tackle these complex neurological disorders. Synergistic therapeutic effects can be obtained from combining customized biomaterial scaffolds with cell-based therapies. Current scaffold-facilitated cell transplantation strategies aim to achieve structural and functional rescue via offering a three-dimensional permissive and instructive environment for sustainable neuroactive factor production for prolonged periods and/or cell replacement at the target site. In this review, we intend to highlight important considerations in biomaterial selection and to review major biodegradable or non-biodegradable scaffolds used for cell transplantation to the central and peripheral nervous system in preclinical and clinical trials. Expanded knowledge in biomaterial properties and their prolonged interaction with transplanted and host cells have greatly expanded the possibilities for designing suitable carrier systems and the potential of cell therapies in the nervous system.
Keywords: age-related neurodegeneration; drug delivery and drug-likeness; blood-brain barrier; biomaterials; cell encapsulation; microcarriers; central nervous system injury; peripheral nervous system
PDF Full-text Download PDF Full-Text [886 KB, uploaded 19 June 2014 05:46 CEST]

Export to BibTeX |

MDPI and ACS Style

Wong, F.S.Y.; Chan, B.P.; Lo, A.C.Y. Carriers in Cell-Based Therapies for Neurological Disorders. Int. J. Mol. Sci. 2014, 15, 10669-10723.

AMA Style

Wong FSY, Chan BP, Lo ACY. Carriers in Cell-Based Therapies for Neurological Disorders. International Journal of Molecular Sciences. 2014; 15(6):10669-10723.

Chicago/Turabian Style

Wong, Francisca S.Y.; Chan, Barbara P.; Lo, Amy C.Y. 2014. "Carriers in Cell-Based Therapies for Neurological Disorders." Int. J. Mol. Sci. 15, no. 6: 10669-10723.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert